www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

Hepatitis C therapy to be improved

By Shan Juan | China Daily | Updated: 2016-12-14 07:31

Hepatitis C patients in China will soon be able to access direct-acting antiviral treatments, which can thoroughly cure the liver infection, a senior liver disease specialist said.

"Several DAA medicines are expected to get approval from the top drug authority and enter the Chinese market early next year, which will bring China's hepatitis C treatment in line with international mainstream practices," said Wei Lai, president of the Chinese Society of Liver Diseases of the Chinese Medical Association.

Currently, most Chinese patients are on injection interferon therapy, which takes longer and may cause serious reactions for some recipients.

DAA, by contrast, is taken orally and can usually get rid of the virus and cure the disease in about 12 weeks.

A patient surnamed Bai is one of those who cannot handle the major side effects from interferon treatment. To survive, he bought DAA drugs from overseas and was cured last year.

DAA medicines have been readily available elsewhere worldwide for many years. But the country with the most patients has no such drugs largely due to "complex and lengthy drug registration processes", according to WHO China Representative Bernhard Schwartlander.

In April, the China Food and Drug Administration announced an acceleration of the registration for DAA.

"That's encouraging, and Chinese patients will be able to access world-class treatments at home," Bai said.

Bai contracted the hepatitis C virus in the late 1980s via a blood transfusion. Viral screenings for hepatitis C and HIV were not integrated into the nation's blood donation drives until 1993, and a number of people became infected from blood transfusions in the late '80s and early '90s, Wei said.

"A majority of Chinese hepatitis C patients were infected during that period and they have now begun to develop cirrhosis of the liver and cancer," he said.

China has about 10 million people with hepatitis C - the highest worldwide - with nearly 60 percent of them becoming infected via blood-related procedures, statistics from the National Health and Family Planning Commission showed.

Other high risk procedures include dental services, endoscopy and dialysis, Wei said.

He urged the government to consider covering DAA under the health insurance program to improve patient access.

"Over the long run, it's cost effective, because treatment for cirrhosis of the liver and cancer costs much more," he said.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 色综合天天综合网看在线影院 | 成人黄色在线免费观看 | 欧美精品一区二区三区四区 | 免费一区二区三区在线视频 | 日本aaaa级毛片在线看 | 美女一级毛片毛片在线播放 | 免费一级欧美大片视频在线 | 91成人免费视频 | 男女男精品视频在线播放 | 男女视频免费 | 久久精品系列 | 国产永久精品 | www.日本在线| 亚洲免费网站观看视频 | 欧美性精品videofree | 男女午夜爱爱久久无遮挡 | 自拍偷自拍亚洲精品一区 | 一级aaa级毛片午夜在线播放 | 国产91免费在线 | 欧美特黄一区二区三区 | 国产免费一级高清淫曰本片 | 欧美亚洲综合网 | 在线播放精品一区二区啪视频 | 日本无遮 | 免费视频久久看 | 亚洲视频精品在线观看 | 国产亚洲精品一品区99热 | 99精品久久秒播无毒不卡 | 国产成人精品高清在线 | 国产3区 | 亚洲 欧美 日韩 在线 中文字幕 | 三级在线国产 | 成年人免费看视频 | 亚洲精品黄色 | 手机在线一区二区三区 | 亚洲视频三级 | 国产一区二区三区手机在线观看 | 久久99国产精品视频 | 久久福利资源站免费观看i 久久高清精品 | 2019偷偷狠狠的日日 | 成人自拍视频网站 |